Comparatively, our study investigated a broader range of inflammatory markers, where, notably, the NLPR and SII demonstrated significant predictive value, with risk ratios indicating a three to three-and-a-half times higher risk of developing SIRS, comparable to CRP levels measured on the first and third days of life. This evidence concerns the gene CRP and systemic inflammatory response syndrome.